Evaluation of Convolutional Neural Networks (CNNs) in Identifying Retinal Conditions Through Classification of Optical Coherence Tomography (OCT) Images

通过对光学相干断层扫描(OCT)图像进行分类,评估卷积神经网络(CNN)在识别视网膜疾病方面的应用

阅读:1

Abstract

Introduction Diabetic retinopathy (DR) is a leading cause of blindness globally, emphasizing the urgent need for efficient diagnostic tools. Machine learning, particularly convolutional neural networks (CNNs), has shown promise in automating the diagnosis of retinal conditions with high accuracy. This study evaluates two CNN models, VGG16 and InceptionV3, for classifying retinal optical coherence tomography (OCT) images into four categories: normal, choroidal neovascularization, diabetic macular edema (DME), and drusen. Methods Using 83,000 OCT images across four categories, the CNNs were trained and tested via Python-based libraries, including TensorFlow and Keras. Metrics such as accuracy, sensitivity, and specificity were analyzed with confusion matrices and performance graphs. Comparisons of dataset sizes evaluated the impact on model accuracy with tools deployed on JupyterLab. Results VGG16 and InceptionV3 achieved accuracy between 85% and 95%, with VGG16 peaking at 94% and outperforming InceptionV3 (92%). Larger datasets improved sensitivity by 7% and accuracy across all categories, with the highest performance for normal and drusen classifications. Metrics like sensitivity and specificity positively correlated with dataset size. Conclusions The study confirms CNNs' potential in retinal diagnostics, achieving high classification accuracy. Limitations included reliance on grayscale images and computational intensity, which hindered finer distinctions. Future work should integrate data augmentation, patient-specific variables, and lightweight architectures to optimize performance for clinical use, reducing costs and improving outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。